Click for best price
Omics Based Clinical Trials Market Size, Share 2023
Omics is?a rapidly evolving, multi-disciplinary, and emerging field that encompasses genomics, epigenomics, transcriptomics, proteomics, and metabolomics.Advanced omics technologies, including single-cell omics and multi-omics, are being used to evaluate a variety of cancer immunotherapies. Furthermore, given the precision medicine environment, the expanding use of multi-omics in research, as well as the penetration of contemporary sequencing technologies, is boosting the market.
This report aims to provide a comprehensive presentation of the global market for Omics Based Clinical Trials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Omics Based Clinical Trials. This report contains market size and forecasts of Omics Based Clinical Trials in global, including the following market information:
Global Omics Based Clinical Trials Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Omics Based Clinical Trials market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Interventional Studies Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Omics Based Clinical Trials include Parexel International Corporation, Pharmaceutical Product Development (PPD), Charles River Laboratory, ICON plc, SGS SA, Eli Lilly and Company, Pfizer, Covance and Rebus Bio, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Omics Based Clinical Trials companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Omics Based Clinical Trials Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Omics Based Clinical Trials Market Segment Percentages, by Type, 2022 (%)
Interventional Studies
Observational Studies
Expanded Access Studies
Global Omics Based Clinical Trials Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Omics Based Clinical Trials Market Segment Percentages, by Application, 2022 (%)
Oncology
Cardiology
Respiratory Diseases
Skin Diseases
CNS Diseases
Immunology
Genetic Diseases
Other Indications
Global Omics Based Clinical Trials Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Omics Based Clinical Trials Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Omics Based Clinical Trials revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Omics Based Clinical Trials revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Parexel International Corporation
Pharmaceutical Product Development (PPD)
Charles River Laboratory
ICON plc
SGS SA
Eli Lilly and Company
Pfizer
Covance
Rebus Bio
Novo Nordisk
Outline of Major Chapters:
Chapter 1: Introduces the definition of Omics Based Clinical Trials, market overview.
Chapter 2: Global Omics Based Clinical Trials market size in revenue.
Chapter 3: Detailed analysis of Omics Based Clinical Trials company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Omics Based Clinical Trials in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Omics Based Clinical Trials Market, Global Outlook and Forecast 2023-2032 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Omics Based Clinical Trials Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Omics Based Clinical Trials Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Omics Based Clinical Trials Overall Market Size
2.1 Global Omics Based Clinical Trials Market Size: 2022 VS 2032
2.2 Global Omics Based Clinical Trials Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Omics Based Clinical Trials Players in Global Market
3.2 Top Global Omics Based Clinical Trials Companies Ranked by Revenue
3.3 Global Omics Based Clinical Trials Revenue by Companies
3.4 Top 3 and Top 5 Omics Based Clinical Trials Companies in Global Market, by Revenue in 2022
3.5 Global Companies Omics Based Clinical Trials Product Type
3.6 Tier 1, Tier 2 and Tier 3 Omics Based Clinical Trials Players in Global Market
3.6.1 List of Global Tier 1 Omics Based Clinical Trials Companies
3.6.2 List of Global Tier 2 and Tier 3 Omics Based Clinical Trials Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Omics Based Clinical Trials Market Size Markets, 2022 & 2032
4.1.2 Interventional Studies
4.1.3 Observational Studies
4.1.4 Expanded Access Studies
4.2 By Type - Global Omics Based Clinical Trials Revenue & Forecasts
4.2.1 By Type - Global Omics Based Clinical Trials Revenue, 2018-2023
4.2.2 By Type - Global Omics Based Clinical Trials Revenue, 2024-2032
4.2.3 By Type - Global Omics Based Clinical Trials Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Omics Based Clinical Trials Market Size, 2022 & 2032
5.1.2 Oncology
5.1.3 Cardiology
5.1.4 Respiratory Diseases
5.1.5 Skin Diseases
5.1.6 CNS Diseases
5.1.7 Immunology
5.1.8 Genetic Diseases
5.1.9 Other Indications
5.2 By Application - Global Omics Based Clinical Trials Revenue & Forecasts
5.2.1 By Application - Global Omics Based Clinical Trials Revenue, 2018-2023
5.2.2 By Application - Global Omics Based Clinical Trials Revenue, 2024-2032
5.2.3 By Application - Global Omics Based Clinical Trials Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Omics Based Clinical Trials Market Size, 2022 & 2032
6.2 By Region - Global Omics Based Clinical Trials Revenue & Forecasts
6.2.1 By Region - Global Omics Based Clinical Trials Revenue, 2018-2023
6.2.2 By Region - Global Omics Based Clinical Trials Revenue, 2024-2032
6.2.3 By Region - Global Omics Based Clinical Trials Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Omics Based Clinical Trials Revenue, 2018-2032
6.3.2 US Omics Based Clinical Trials Market Size, 2018-2032
6.3.3 Canada Omics Based Clinical Trials Market Size, 2018-2032
6.3.4 Mexico Omics Based Clinical Trials Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Omics Based Clinical Trials Revenue, 2018-2032
6.4.2 Germany Omics Based Clinical Trials Market Size, 2018-2032
6.4.3 France Omics Based Clinical Trials Market Size, 2018-2032
6.4.4 U.K. Omics Based Clinical Trials Market Size, 2018-2032
6.4.5 Italy Omics Based Clinical Trials Market Size, 2018-2032
6.4.6 Russia Omics Based Clinical Trials Market Size, 2018-2032
6.4.7 Nordic Countries Omics Based Clinical Trials Market Size, 2018-2032
6.4.8 Benelux Omics Based Clinical Trials Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Omics Based Clinical Trials Revenue, 2018-2032
6.5.2 China Omics Based Clinical Trials Market Size, 2018-2032
6.5.3 Japan Omics Based Clinical Trials Market Size, 2018-2032
6.5.4 South Korea Omics Based Clinical Trials Market Size, 2018-2032
6.5.5 Southeast Asia Omics Based Clinical Trials Market Size, 2018-2032
6.5.6 India Omics Based Clinical Trials Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Omics Based Clinical Trials Revenue, 2018-2032
6.6.2 Brazil Omics Based Clinical Trials Market Size, 2018-2032
6.6.3 Argentina Omics Based Clinical Trials Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Omics Based Clinical Trials Revenue, 2018-2032
6.7.2 Turkey Omics Based Clinical Trials Market Size, 2018-2032
6.7.3 Israel Omics Based Clinical Trials Market Size, 2018-2032
6.7.4 Saudi Arabia Omics Based Clinical Trials Market Size, 2018-2032
6.7.5 UAE Omics Based Clinical Trials Market Size, 2018-2032
7 Omics Based Clinical Trials Companies Profiles
7.1 Parexel International Corporation
7.1.1 Parexel International Corporation Company Summary
7.1.2 Parexel International Corporation Business Overview
7.1.3 Parexel International Corporation Omics Based Clinical Trials Major Product Offerings
7.1.4 Parexel International Corporation Omics Based Clinical Trials Revenue in Global Market (2018-2023)
7.1.5 Parexel International Corporation Key News & Latest Developments
7.2 Pharmaceutical Product Development (PPD)
7.2.1 Pharmaceutical Product Development (PPD) Company Summary
7.2.2 Pharmaceutical Product Development (PPD) Business Overview
7.2.3 Pharmaceutical Product Development (PPD) Omics Based Clinical Trials Major Product Offerings
7.2.4 Pharmaceutical Product Development (PPD) Omics Based Clinical Trials Revenue in Global Market (2018-2023)
7.2.5 Pharmaceutical Product Development (PPD) Key News & Latest Developments
7.3 Charles River Laboratory
7.3.1 Charles River Laboratory Company Summary
7.3.2 Charles River Laboratory Business Overview
7.3.3 Charles River Laboratory Omics Based Clinical Trials Major Product Offerings
7.3.4 Charles River Laboratory Omics Based Clinical Trials Revenue in Global Market (2018-2023)
7.3.5 Charles River Laboratory Key News & Latest Developments
7.4 ICON plc
7.4.1 ICON plc Company Summary
7.4.2 ICON plc Business Overview
7.4.3 ICON plc Omics Based Clinical Trials Major Product Offerings
7.4.4 ICON plc Omics Based Clinical Trials Revenue in Global Market (2018-2023)
7.4.5 ICON plc Key News & Latest Developments
7.5 SGS SA
7.5.1 SGS SA Company Summary
7.5.2 SGS SA Business Overview
7.5.3 SGS SA Omics Based Clinical Trials Major Product Offerings
7.5.4 SGS SA Omics Based Clinical Trials Revenue in Global Market (2018-2023)
7.5.5 SGS SA Key News & Latest Developments
7.6 Eli Lilly and Company
7.6.1 Eli Lilly and Company Company Summary
7.6.2 Eli Lilly and Company Business Overview
7.6.3 Eli Lilly and Company Omics Based Clinical Trials Major Product Offerings
7.6.4 Eli Lilly and Company Omics Based Clinical Trials Revenue in Global Market (2018-2023)
7.6.5 Eli Lilly and Company Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Omics Based Clinical Trials Major Product Offerings
7.7.4 Pfizer Omics Based Clinical Trials Revenue in Global Market (2018-2023)
7.7.5 Pfizer Key News & Latest Developments
7.8 Covance
7.8.1 Covance Company Summary
7.8.2 Covance Business Overview
7.8.3 Covance Omics Based Clinical Trials Major Product Offerings
7.8.4 Covance Omics Based Clinical Trials Revenue in Global Market (2018-2023)
7.8.5 Covance Key News & Latest Developments
7.9 Rebus Bio
7.9.1 Rebus Bio Company Summary
7.9.2 Rebus Bio Business Overview
7.9.3 Rebus Bio Omics Based Clinical Trials Major Product Offerings
7.9.4 Rebus Bio Omics Based Clinical Trials Revenue in Global Market (2018-2023)
7.9.5 Rebus Bio Key News & Latest Developments
7.10 Novo Nordisk
7.10.1 Novo Nordisk Company Summary
7.10.2 Novo Nordisk Business Overview
7.10.3 Novo Nordisk Omics Based Clinical Trials Major Product Offerings
7.10.4 Novo Nordisk Omics Based Clinical Trials Revenue in Global Market (2018-2023)
7.10.5 Novo Nordisk Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Omics Based Clinical Trials Market Opportunities & Trends in Global Market
Table 2. Omics Based Clinical Trials Market Drivers in Global Market
Table 3. Omics Based Clinical Trials Market Restraints in Global Market
Table 4. Key Players of Omics Based Clinical Trials in Global Market
Table 5. Top Omics Based Clinical Trials Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Omics Based Clinical Trials Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Omics Based Clinical Trials Revenue Share by Companies, 2018-2023
Table 8. Global Companies Omics Based Clinical Trials Product Type
Table 9. List of Global Tier 1 Omics Based Clinical Trials Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Omics Based Clinical Trials Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Omics Based Clinical Trials Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Omics Based Clinical Trials Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Omics Based Clinical Trials Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Omics Based Clinical Trials Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Omics Based Clinical Trials Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Omics Based Clinical Trials Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Omics Based Clinical Trials Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Omics Based Clinical Trials Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Omics Based Clinical Trials Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Omics Based Clinical Trials Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Omics Based Clinical Trials Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Omics Based Clinical Trials Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Omics Based Clinical Trials Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Omics Based Clinical Trials Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Omics Based Clinical Trials Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Omics Based Clinical Trials Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Omics Based Clinical Trials Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Omics Based Clinical Trials Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Omics Based Clinical Trials Revenue, (US$, Mn), 2024-2032
Table 30. Parexel International Corporation Company Summary
Table 31. Parexel International Corporation Omics Based Clinical Trials Product Offerings
Table 32. Parexel International Corporation Omics Based Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 33. Parexel International Corporation Key News & Latest Developments
Table 34. Pharmaceutical Product Development (PPD) Company Summary
Table 35. Pharmaceutical Product Development (PPD) Omics Based Clinical Trials Product Offerings
Table 36. Pharmaceutical Product Development (PPD) Omics Based Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 37. Pharmaceutical Product Development (PPD) Key News & Latest Developments
Table 38. Charles River Laboratory Company Summary
Table 39. Charles River Laboratory Omics Based Clinical Trials Product Offerings
Table 40. Charles River Laboratory Omics Based Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 41. Charles River Laboratory Key News & Latest Developments
Table 42. ICON plc Company Summary
Table 43. ICON plc Omics Based Clinical Trials Product Offerings
Table 44. ICON plc Omics Based Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 45. ICON plc Key News & Latest Developments
Table 46. SGS SA Company Summary
Table 47. SGS SA Omics Based Clinical Trials Product Offerings
Table 48. SGS SA Omics Based Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 49. SGS SA Key News & Latest Developments
Table 50. Eli Lilly and Company Company Summary
Table 51. Eli Lilly and Company Omics Based Clinical Trials Product Offerings
Table 52. Eli Lilly and Company Omics Based Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 53. Eli Lilly and Company Key News & Latest Developments
Table 54. Pfizer Company Summary
Table 55. Pfizer Omics Based Clinical Trials Product Offerings
Table 56. Pfizer Omics Based Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 57. Pfizer Key News & Latest Developments
Table 58. Covance Company Summary
Table 59. Covance Omics Based Clinical Trials Product Offerings
Table 60. Covance Omics Based Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 61. Covance Key News & Latest Developments
Table 62. Rebus Bio Company Summary
Table 63. Rebus Bio Omics Based Clinical Trials Product Offerings
Table 64. Rebus Bio Omics Based Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 65. Rebus Bio Key News & Latest Developments
Table 66. Novo Nordisk Company Summary
Table 67. Novo Nordisk Omics Based Clinical Trials Product Offerings
Table 68. Novo Nordisk Omics Based Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 69. Novo Nordisk Key News & Latest Developments
List of Figures
Figure 1. Omics Based Clinical Trials Segment by Type in 2022
Figure 2. Omics Based Clinical Trials Segment by Application in 2022
Figure 3. Global Omics Based Clinical Trials Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Omics Based Clinical Trials Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Omics Based Clinical Trials Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Omics Based Clinical Trials Revenue in 2022
Figure 8. By Type - Global Omics Based Clinical Trials Revenue Market Share, 2018-2032
Figure 9. By Application - Global Omics Based Clinical Trials Revenue Market Share, 2018-2032
Figure 10. By Type - Global Omics Based Clinical Trials Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Omics Based Clinical Trials Revenue Market Share, 2018-2032
Figure 12. By Application - Global Omics Based Clinical Trials Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Omics Based Clinical Trials Revenue Market Share, 2018-2032
Figure 14. By Region - Global Omics Based Clinical Trials Revenue Market Share, 2018-2032
Figure 15. By Country - North America Omics Based Clinical Trials Revenue Market Share, 2018-2032
Figure 16. US Omics Based Clinical Trials Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Omics Based Clinical Trials Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Omics Based Clinical Trials Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Omics Based Clinical Trials Revenue Market Share, 2018-2032
Figure 20. Germany Omics Based Clinical Trials Revenue, (US$, Mn), 2018-2032
Figure 21. France Omics Based Clinical Trials Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Omics Based Clinical Trials Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Omics Based Clinical Trials Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Omics Based Clinical Trials Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Omics Based Clinical Trials Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Omics Based Clinical Trials Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Omics Based Clinical Trials Revenue Market Share, 2018-2032
Figure 28. China Omics Based Clinical Trials Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Omics Based Clinical Trials Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Omics Based Clinical Trials Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Omics Based Clinical Trials Revenue, (US$, Mn), 2018-2032
Figure 32. India Omics Based Clinical Trials Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Omics Based Clinical Trials Revenue Market Share, 2018-2032
Figure 34. Brazil Omics Based Clinical Trials Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Omics Based Clinical Trials Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Omics Based Clinical Trials Revenue Market Share, 2018-2032
Figure 37. Turkey Omics Based Clinical Trials Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Omics Based Clinical Trials Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Omics Based Clinical Trials Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Omics Based Clinical Trials Revenue, (US$, Mn), 2018-2032
Figure 41. Parexel International Corporation Omics Based Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pharmaceutical Product Development (PPD) Omics Based Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Charles River Laboratory Omics Based Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. ICON plc Omics Based Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. SGS SA Omics Based Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Eli Lilly and Company Omics Based Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Pfizer Omics Based Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Covance Omics Based Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Rebus Bio Omics Based Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Novo Nordisk Omics Based Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
